Arrowhead Pharmaceuticals (ARWR) Exchange Rate Effect (2021 - 2026)
Arrowhead Pharmaceuticals' (ARWR) quarterly Exchange Rate Effect came in at $997000.0 in Q1 2026, up 348.01% YoY from $222539.7 in Q1 2025, and up 840.57% on a QoQ basis from $106000.0 in Q4 2025.
Powered by 
Analysis
Arrowhead Pharmaceuticals (ARWR) Exchange Rate Effect (2021 - 2026) Analysis & Trends
Arrowhead Pharmaceuticals (ARWR) has 6 years of Exchange Rate Effect data on file, last reported at $997000.0 in Q1 2026.
- Quarterly Exchange Rate Effect rose 348.01% year-over-year to $997000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (down 67.83% YoY) and the FY2025 annual result came in at -$401000.0, down 109.55% from the prior year.
- Exchange Rate Effect rose to $997000.0 in Q1 2026, from $106000.0 in the prior quarter.
- In the past five years, Exchange Rate Effect ranged from a high of $4.3 million in Q3 2024 to a low of -$402000.0 in Q1 2025.
- A 5-year average of $279352.9 and a median of $1000.0 in 2022 frame the typical range for Exchange Rate Effect.
- The widest YoY moves for Exchange Rate Effect: up 5000.0% in 2023, down 7500.0% in 2023.
- Tracing ARWR's Exchange Rate Effect over 5 years: stood at -$122000.0 in 2022, then soared by 147.54% to $58000.0 in 2023, then slumped by 217.24% to -$68000.0 in 2024, then jumped by 255.88% to $106000.0 in 2025, then soared by 840.57% to $997000.0 in 2026.
- The last three Exchange Rate Effect figures came in at $997000.0 (Q1 2026), $106000.0 (Q4 2025), and -$24000.0 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -3.70 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -300,000.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -2.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 19.84 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -287,000.00 |
| 10 | Arrowhead Pharmaceuticals | 12.40 Bn | 10.80 Bn | - | 477,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 477,000.00 |
| Mar 31, 2026 | 997,000.00 |
| Dec 31, 2025 | 106,000.00 |
| Sep 30, 2025 | -24,000.00 |
| Jun 30, 2025 | 93,000.00 |
| Mar 31, 2025 | -402,000.00 |
| Dec 31, 2024 | -68,000.00 |
| Sep 30, 2024 | 4.34 Mn |
| Jun 30, 2024 | -223,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Dec 31, 2023 | 58,000.00 |
| Sep 30, 2023 | 153,000.00 |
| Jun 30, 2023 | -79,000.00 |
| Mar 31, 2023 | -74,000.00 |
| Dec 31, 2022 | -122,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | -32,000.00 |
| Mar 31, 2022 | 1,000.00 |
| Dec 31, 2021 | -39,000.00 |